The global healthcare cybersecurity market size was USD 23.30 billion in 2023, estimated at USD 27.26 billion in 2024 and is anticipated to reach around USD 126.70 billion by 2034, expanding at a CAGR of 16.61% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Healthcare Cybersecurity Market, by Offering, 2024-2034
7.1.1. Solutions
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Services
7.1.2.1. Market Revenue and Forecast (2021-2034)
8.1. Healthcare Cybersecurity Market, by Security, 2024-2034
8.1.1. Cloud security
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Network security
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Application security
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Endpoint security
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Healthcare Cybersecurity Market, by Threat Type, 2024-2034
9.1.1. Ransomware
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Malware & Spyware
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Distributed Denial of Service (DDoS)
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Phishing & spear phishing
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Healthcare Cybersecurity Market, by Deployment, 2024-2034
10.1.1. On-premises
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Cloud-based
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Healthcare Cybersecurity Market, by End-use, 2024-2034
11.1.1. Healthcare Payers
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Healthcare Providers
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. Healthcare Cybersecurity Market, by Application, 2024-2034
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Pharmaceutical and biotechnology industries
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Healthcare payers
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2021-2034)
13.1. Healthcare Cybersecurity Market, by Solution, 2024-2034
13.1.1. Identity and Access Management
13.1.1.1. Market Revenue and Forecast (2021-2034)
13.1.2. Risk and Compliance Management
13.1.2.1. Market Revenue and Forecast (2021-2034)
13.1.3. Antivirus and Antimalware
13.1.3.1. Market Revenue and Forecast (2021-2034)
13.1.4. DDoS Mitigation
13.1.4.1. Market Revenue and Forecast (2021-2034)
13.1.5. Security Information and Event Management
13.1.5.1. Market Revenue and Forecast (2021-2034)
13.1.6. Intrusion Detection System/ Intrusion Prevention System
13.1.6.1. Market Revenue and Forecast (2021-2034)
13.1.7. Others
13.1.7.1. Market Revenue and Forecast (2021-2034)
14.1. North America
14.1.1. Market Revenue and Forecast, by Offering (2021-2034)
14.1.2. Market Revenue and Forecast, by Security (2021-2034)
14.1.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.1.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.1.5. Market Revenue and Forecast, by End-use (2021-2034)
14.1.6. Market Revenue and Forecast, by Solution (2021-2034)
14.1.7. Market Revenue and Forecast, by Application (2021-2034)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Offering (2021-2034)
14.1.8.2. Market Revenue and Forecast, by Security (2021-2034)
14.1.8.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.1.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.1.8.5. Market Revenue and Forecast, by End-use (2021-2034)
14.1.8.6. Market Revenue and Forecast, by Solution (2021-2034)
14.1.8.7. Market Revenue and Forecast, by Application (2021-2034)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Offering (2021-2034)
14.1.9.2. Market Revenue and Forecast, by Security (2021-2034)
14.1.9.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.1.9.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.1.9.5. Market Revenue and Forecast, by End-use (2021-2034)
14.1.9.6. Market Revenue and Forecast, by Solution (2021-2034)
14.1.9.7. Market Revenue and Forecast, by Application (2021-2034)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Offering (2021-2034)
14.2.2. Market Revenue and Forecast, by Security (2021-2034)
14.2.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.2.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.2.5. Market Revenue and Forecast, by End-use (2021-2034)
14.2.6. Market Revenue and Forecast, by Solution (2021-2034)
14.2.7. Market Revenue and Forecast, by Application (2021-2034)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Offering (2021-2034)
14.2.8.2. Market Revenue and Forecast, by Security (2021-2034)
14.2.8.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.2.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.2.8.5. Market Revenue and Forecast, by End-use (2021-2034)
14.2.8.6. Market Revenue and Forecast, by Solution (2021-2034)
14.2.8.7. Market Revenue and Forecast, by Application (2021-2034)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Offering (2021-2034)
14.2.9.2. Market Revenue and Forecast, by Security (2021-2034)
14.2.9.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.2.9.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.2.9.5. Market Revenue and Forecast, by End-use (2021-2034)
14.2.9.6. Market Revenue and Forecast, by Solution (2021-2034)
14.2.9.7. Market Revenue and Forecast, by Application (2021-2034)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Offering (2021-2034)
14.2.10.2. Market Revenue and Forecast, by Security (2021-2034)
14.2.10.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.2.10.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.2.10.5. Market Revenue and Forecast, by End-use (2021-2034)
14.2.10.6. Market Revenue and Forecast, by Solution (2021-2034)
14.2.10.7. Market Revenue and Forecast, by Application (2021-2034)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Offering (2021-2034)
14.2.11.2. Market Revenue and Forecast, by Security (2021-2034)
14.2.11.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.2.11.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.2.11.5. Market Revenue and Forecast, by End-use (2021-2034)
14.2.11.6. Market Revenue and Forecast, by Solution (2021-2034)
14.2.11.7. Market Revenue and Forecast, by Application (2021-2034)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Offering (2021-2034)
14.3.2. Market Revenue and Forecast, by Security (2021-2034)
14.3.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.3.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.3.5. Market Revenue and Forecast, by End-use (2021-2034)
14.3.6. Market Revenue and Forecast, by Solution (2021-2034)
14.3.7. Market Revenue and Forecast, by Application (2021-2034)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Offering (2021-2034)
14.3.8.2. Market Revenue and Forecast, by Security (2021-2034)
14.3.8.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.3.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.3.8.5. Market Revenue and Forecast, by End-use (2021-2034)
14.3.8.6. Market Revenue and Forecast, by Solution (2021-2034)
14.3.8.7. Market Revenue and Forecast, by Application (2021-2034)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Offering (2021-2034)
14.3.9.2. Market Revenue and Forecast, by Security (2021-2034)
14.3.9.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.3.9.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.3.9.5. Market Revenue and Forecast, by End-use (2021-2034)
14.3.9.6. Market Revenue and Forecast, by Solution (2021-2034)
14.3.9.7. Market Revenue and Forecast, by Application (2021-2034)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Offering (2021-2034)
14.3.10.2. Market Revenue and Forecast, by Security (2021-2034)
14.3.10.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.3.10.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.3.10.5. Market Revenue and Forecast, by End-use (2021-2034)
14.3.10.6. Market Revenue and Forecast, by Solution (2021-2034)
14.3.10.7. Market Revenue and Forecast, by Application (2021-2034)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Offering (2021-2034)
14.3.11.2. Market Revenue and Forecast, by Security (2021-2034)
14.3.11.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.3.11.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.3.11.5. Market Revenue and Forecast, by End-use (2021-2034)
14.3.11.6. Market Revenue and Forecast, by Solution (2021-2034)
14.3.11.7. Market Revenue and Forecast, by Application (2021-2034)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Offering (2021-2034)
14.4.2. Market Revenue and Forecast, by Security (2021-2034)
14.4.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.4.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.4.5. Market Revenue and Forecast, by End-use (2021-2034)
14.4.6. Market Revenue and Forecast, by Solution (2021-2034)
14.4.7. Market Revenue and Forecast, by Application (2021-2034)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Offering (2021-2034)
14.4.8.2. Market Revenue and Forecast, by Security (2021-2034)
14.4.8.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.4.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.4.8.5. Market Revenue and Forecast, by End-use (2021-2034)
14.4.8.6. Market Revenue and Forecast, by Solution (2021-2034)
14.4.8.7. Market Revenue and Forecast, by Application (2021-2034)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Offering (2021-2034)
14.4.9.2. Market Revenue and Forecast, by Security (2021-2034)
14.4.9.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.4.9.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.4.9.5. Market Revenue and Forecast, by End-use (2021-2034)
14.4.9.6. Market Revenue and Forecast, by Solution (2021-2034)
14.4.9.7. Market Revenue and Forecast, by Application (2021-2034)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Offering (2021-2034)
14.4.10.2. Market Revenue and Forecast, by Security (2021-2034)
14.4.10.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.4.10.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.4.10.5. Market Revenue and Forecast, by End-use (2021-2034)
14.4.10.6. Market Revenue and Forecast, by Solution (2021-2034)
14.4.10.7. Market Revenue and Forecast, by Application (2021-2034)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Offering (2021-2034)
14.4.11.2. Market Revenue and Forecast, by Security (2021-2034)
14.4.11.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.4.11.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.4.11.5. Market Revenue and Forecast, by End-use (2021-2034)
14.4.11.6. Market Revenue and Forecast, by Solution (2021-2034)
14.4.11.7. Market Revenue and Forecast, by Application (2021-2034)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Offering (2021-2034)
14.5.2. Market Revenue and Forecast, by Security (2021-2034)
14.5.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.5.5. Market Revenue and Forecast, by End-use (2021-2034)
14.5.6. Market Revenue and Forecast, by Solution (2021-2034)
14.5.7. Market Revenue and Forecast, by Application (2021-2034)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Offering (2021-2034)
14.5.8.2. Market Revenue and Forecast, by Security (2021-2034)
14.5.8.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.5.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.5.8.5. Market Revenue and Forecast, by End-use (2021-2034)
14.5.8.6. Market Revenue and Forecast, by Solution (2021-2034)
14.5.8.7. Market Revenue and Forecast, by Application (2021-2034)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Offering (2021-2034)
14.5.9.2. Market Revenue and Forecast, by Security (2021-2034)
14.5.9.3. Market Revenue and Forecast, by Threat Type (2021-2034)
14.5.9.4. Market Revenue and Forecast, by Deployment (2021-2034)
14.5.9.5. Market Revenue and Forecast, by End-use (2021-2034)
14.5.9.6. Market Revenue and Forecast, by Solution (2021-2034)
14.5.9.7. Market Revenue and Forecast, by Application (2021-2034)
15.1. SYMANTEC CORPORATION
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Cisco Systems, Inc.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. FireEye, Inc.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. NORTHROP GRUMMA CORPORATION
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Palo Alto Networks, Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. sensato investors
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Lockheed Martin Corporation
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. MACAFEE, INC.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. ibm corporation
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Kaspersky Lab
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client